Truveta

Yesterday was a busy day at #ISPOR2026! Some highlights: 1️⃣ SVP of Product Michael Simonov shared how AI and RWD can shorten evidence timelines, delivering insights in minutes, not months in his theater presentation. 2️⃣ Senior Research Analyst Karen Gilbert Farrar, PhD and ML Postdoc Researcher Youngwon Kim presented research posters, one on gestational weight changes and the effect on newborn weight (https://tr.vet/49D9Xgs), and another on mapping oncology patient journeys (https://tr.vet/4nIO8SG). 3️⃣ We had a special guest at the booth, showing attendees the art of the paw-sible: Cooper from the Alliance of Therapy Dogs 🐾 Stay tuned for more ISPOR updates! ISPOR—The Professional Society for Health Economics and Outcomes Research

Last night, we kicked off #ISPOR2026 in Philadelphia with leaders across life sciences and healthcare for an evening focused on connecting ideas, data, and people. Thank you to everyone who joined us and helped make the event such a success 👏 It was an energizing start to the week with great conversations around real-world evidence, HEOR, and the future of data-driven healthcare decision-making. Attending ISPOR? Don’t forget to stop by our booth (#505) to say hello 👋 We’d love to connect and share how Truveta can help advance evidence generation at scale. ISPOR—The Professional Society for Health Economics and Outcomes Research

Clinical AI is accelerating access to medical evidence in powerful ways. But clinicians also need answers grounded in the experiences of patients who resemble the ones sitting in front of them. In this piece, Truveta President and Chief Scientific Officer Johnathan M. Lancaster, MD PhD explores why the future of clinical decision support will combine published literature with real-world data—bringing together published literature and real-time insights from Truveta Intelligence to help clinicians get faster, more contextual answers at the point of care.

Our fourth annual symposium brought together leaders across healthcare for a packed week of discussion, collaboration, and connection in Seattle 📍 From mainstage discussions to hands-on demos and candid conversations, the focus was on how we move faster from data to evidence and from insight to impact for patients. Check out this recap from Truveta Symposium 2026 ⬇️

At Truveta Symposium 2026, we unveiled Truveta Intelligence: a new, AI-powered experience that delivers real-time insights from continuously refreshed, real-world data in minutes, not months. We sat down with team members from across the organization to ask them about how Intelligence can help shorten timelines between question and answer. With each answer, you get data-backed intelligence built on the 130 million patient records in Truveta Data. Learn more: https://tr.vet/435Ihgv

⏰ Just a few days left until #ISPOR2026 kicks off, and we're excited to share the research from our engineering team that we'll be presenting at the event. From zero-shot lung cancer risk prediction to modeling oncology patient journeys and advancing approaches for cancer screening and data completeness, we can't wait to share the findings next week. 🔗 Learn more about Truveta's ISPOR activities: https://tr.vet/4n9ONfG ISPOR—The Professional Society for Health Economics and Outcomes Research

Hantavirus is extremely rare in the US, but in documented clinical cases, hospitalization can happen quickly. After recent hantavirus headlines, Truveta Research analyzed documented diagnoses of hantavirus in Truveta Data from 2018 through April 2026. Key findings: 🔎Researchers identified 151 patients with documented hantavirus diagnoses—roughly 0.3 cases per 1 million patients seeking care each quarter. 🏥Nearly half had evidence of hospitalization within 14 days. ⌛Among those hospitalized, 85% were hospitalized prior to or within the first week of diagnosis. Read the analysis: https://tr.vet/4wsdN5T For a look at how this question moved from Truveta Intelligence to Truveta Research, read Terry Myerson’s perspective: https://tr.vet/4d5ch21

Collaboration is essential to advancing the next generation of clinical AI. We’re pleased to support Knit Health as they introduce their Large Clinical Behavior Model (LCBM), designed to learn from real-world care patterns and help health systems better coordinate care. Truveta’s role in this work is providing high-quality, de-identified patient journey data to help ensure models are grounded in how care is actually delivered across diverse clinical settings. We look forward to continued collaboration that responsibly accelerates innovation and improves patient outcomes. Learn more: https://tr.vet/48SnRen

Next week at #ISPOR2026, SVP of Product Michael Simonov will share how AI and RWD can shorten evidence timelines from months to minutes—helping organizations explore treatment patterns, refine strategy, and act on insights in real time. After the presentation, join us for Truveta’s happy hour at booth #505 at 5pm. Learn more: https://tr.vet/4n9ONfG ISPOR—The Professional Society for Health Economics and Outcomes Research

Headed to Chicago for #ASCO2026? Stop by booth #10066 to learn about oncology data from Truveta. We can't wait to connect with leaders in oncology and learn what's at the forefront of improving care for patients.  Don't forget to book time with our on-site team here: https://tr.vet/4nhcUcn American Society of Clinical Oncology (ASCO)